COMMUNIQUÉS West-GlobeNewswire

H-CYTE Bolsters Board of Directors With Appointment of Dr. Andre Terzic to Board of Directors

29/07/2019 - 14:00

TAMPA, Fla., July 29, 2019 (GLOBE NEWSWIRE) -- H-CYTE Inc. (OTCQB: HCYT) (“H-CYTE” or the “Company”), the owner and operator of innovative medical technology products and services including Lung Health Institute , today [...]

Athenex, Inc. to Report Second Quarter 2019 Earnings Results on August 7, 2019

29/07/2019 - 14:00

BUFFALO, N.Y., July 29, 2019 (GLOBE NEWSWIRE) -- Athenex, Inc. (Nasdaq: ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of [...]

Rhythm Pharmaceuticals Announces Positive Opinion by the European Medicines Agency on Orphan Drug Designation for Setmelanotide for the Treatment of Bardet-Biedl Syndrome

29/07/2019 - 14:00

BOSTON, July 29, 2019 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq:RYTM), a biopharmaceutical company focused on the development and commercialization of therapeutics for the treatment of rare genetic [...]

Ascendis Pharma A/S Announces Participation in August Investor Conferences

29/07/2019 - 14:00

COPENHAGEN, Denmark, July 29, 2019 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative TransCon™ technologies to address unmet medical needs, today announced [...]

Avinger Announces Pantheris SV Limited Launch and Successful Treatment of First Patients in the United States

29/07/2019 - 14:00

REDWOOD CITY, Calif., July 29, 2019 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq: AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for [...]

Appendix 4C– June 2019 Quarter

29/07/2019 - 14:00

Positive results from two prostate cancer trials Phase 2 trial design gaining momentum Investigational New Drug Application to be submitted to FDA in Q3 2019 Pipeline developing based on drug discovery program Board [...]

Spring Bank Announces FDA Acceptance of IND Application for SB 11285, an IV-Administered STING Agonist, for the Treatment of Advanced Solid Tumors

29/07/2019 - 14:00

IV-Administered SB 11285 Phase 1 Trial Planned to Initiate in Coming Weeks HOPKINTON, Mass., July 29, 2019 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (Nasdaq: SBPH), a clinical-stage biopharmaceutical company [...]

Crinetics Pharmaceuticals to Receive Final Award of SBIR Grant from NIH for Congenital Hyperinsulinism

29/07/2019 - 13:30

SAN DIEGO, July 29, 2019 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for [...]

Alkahest Phase 2a Study AKST4290-202 in Refractory Neovascular AMD meets Primary and Secondary Endpoints

29/07/2019 - 13:30

SAN CARLOS, Calif., July 29, 2019 (GLOBE NEWSWIRE) -- Alkahest, Inc., a clinical stage biotechnology company focused on developing transformative therapies to treat age-related diseases, announced that its phase 2a [...]

Arbutus to Report Second Quarter 2019 Financial Results

29/07/2019 - 13:30

WARMINSTER, Pa., July 29, 2019 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), an industry-leading Hepatitis B Virus (HBV) therapeutic solutions company, today announced that it has scheduled its [...]

Plus Therapeutics, Inc. Announces Nasdaq Ticker Symbol Changes and Reverse Stock Split

29/07/2019 - 13:30

AUSTIN, Texas, July 29, 2019 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”) today announced that the Company has officially changed its name from “Cytori Therapeutics, Inc.” to “Plus [...]

Radient Technologies Inc. Issues Shares For Services

29/07/2019 - 13:30

EDMONTON, Alberta, July 29, 2019 (GLOBE NEWSWIRE) -- Radient Technologies Inc. (“Radient” or the “Company”) ( TSX Venture: RTI; OTCQX: RDDTF ) has issued an aggregate of 93,151 common shares to a third party consultant [...]

Unum Therapeutics Announces New Appointments to its Board of Directors

29/07/2019 - 13:05

CAMBRIDGE, Mass., July 29, 2019 (GLOBE NEWSWIRE) -- Unum Therapeutics Inc. (NASDAQ: UMRX), a clinical-stage biopharmaceutical company focused on the development of cellular immunotherapies to treat cancer based on its [...]

Axogen, Inc. to Participate at Canaccord Genuity 39th Annual Growth Conference

29/07/2019 - 13:00

ALACHUA, Fla., July 29, 2019 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for damage or transection to peripheral nerves, today announced [...]

Akcea Therapeutics to Hold Second Quarter 2019 Financial Results Webcast

29/07/2019 - 13:00

Webcast scheduled for Tuesday, August 6th at 4:30 p.m. Eastern Time BOSTON, July 29, 2019 (GLOBE NEWSWIRE) -- Akcea Therapeutics, Inc. (Nasdaq:AKCA), an affiliate of Ionis Pharmaceuticals, Inc., announced today that it [...]

Avadel Pharmaceuticals to Report Second Quarter 2019 Financial Results

29/07/2019 - 13:00

DUBLIN, Ireland, July 29, 2019 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on developing FT218 for narcolepsy, today announced that it will host a conference call and live webcast [...]

Anavex Life Sciences Receives Positive Opinion for Orphan Designation from the European Medicines Agency for ANAVEX®2-73 for the Treatment of Rett Syndrome

29/07/2019 - 13:00

NEW YORK, July 29, 2019 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of [...]

Arvinas Appoints Ronald Peck, M.D. as Chief Medical Officer

29/07/2019 - 13:00

NEW HAVEN, Conn., July 29, 2019 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a biotechnology company creating a new class of drugs based on targeted protein degradation, announced today the appointment of Ronald [...]

Protalix BioTherapeutics Appoints Eyal Rubin as its New Senior Vice President and Chief Financial Officer

29/07/2019 - 13:00

CARMIEL, Israel, July 29, 2019 (GLOBE NEWSWIRE) -- Protalix BioTherapeutics, Inc. (NYSE American:PLX) (TASE:PLX) today announced that Eyal Rubin has been appointed to serve as the Company’s new Senior Vice President and [...]